Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.

NCT00035451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

658

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Azimilide Dihydrochloride
DRUG: Placebo
DRUG: Sotalol

Sponsor

Forest Laboratories